UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides a new and unexpected therapeutic target for new drug development.
The University of California San Diego has been recognized as one of the top schools in the nation for launching students of all backgrounds into successful futures. The campus was ranked 9th in the nation in Money Magazine’s “2019 Best Colleges for Your Money” report.
UC San Diego engineers have developed the thinnest optical device in the world: a waveguide that is three layers of atoms thin. The work is a proof of concept for scaling down optical devices to sizes that are orders of magnitude smaller than today’s devices.
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
UC San Diego, UC Berkeley, and the University of Washington have been awarded a five-year, $5 million grant by the National Science Foundation (NSF) to develop CloudBank, a suite of managed services to simplify public cloud access for computer science research and education.
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.
The heart transplant program at UC San Diego Health has demonstrated the best one-year survival rate for patients in the United States among health care providers with a volume of more than 50 heart transplants per year, according to the Scientific Registry of Transplant Recipients.
Foreign-born Ph.D. graduates with science and engineering degrees from American universities apply to and receive offers for technology startup jobs at the same rate as U.S. citizens, but are only half as likely to actually work at fledgling companies, finds a study from Cornell and UC San Diego.